Treatment of Hemophilia With Genetic Engineering

Rituximab for Treatment of Hemophilia A with High-Responder Inhibitors

Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...

modern surgical techniques in treatment of patients with cleft lip & cleft palate

چکیده ندارد.

The Current Status of Bone Marrow Transplantation in Treatment of Patients with Hemophilia

Background Bone marrow transplantation (BMT)is nowadays used in various hematological disorders including leukemias. Hemophilia A & B are sex linked bleeding disorders in which there are various genetic abnormalities in factor VIII & IX genes. Among various hematological disorders, bleeding disorders mainly hemophilia in now widely treated using plasma derived and recombinant factor VIII & IX ...

etiology, significance, diagnosis and treatment of bruxiam

چکیده ندارد.

Hemophilia — Symptoms and Treatment